Healthy adult
Conditions
Interventions
6-week intake of the test food Wash out 6-week intake of the placebo
6-week intake of the placebo Wash out 6-week intake of the test food
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age: 20 years or older, less than 65 years 2.Gender: Male and female Japanese nationality 3.Patients who have shown a serum uric acid level of 7.9 mg/dl or higher and 6.6 mg/dl or lower in both the primary screening and the secondary screening.
Exclusion criteria
Exclusion criteria: 1.Persons with or who have a history of diseases such as diabetes mellitus, liver disease, kidney disease, or heart disease. 2.Currently, exercise therapy and diet therapy are performed under the supervision of a physician. 3.Persons with diseases requiring continuous medication 4.Persons with a history of serious illness requiring medication. 5.Patients with a history of drug or food allergy 6.Patients who are currently taking health foods and supplements that affect uric acid levels (e.g., those containing chitosan, anserine, chrysanthemum polyphenols, PA-3, etc.) 7.Subjects who are currently taking drugs or quasi-drugs that affect uric acid levels 8.Anthropometric, physical examination, and laboratory test values that significantly deviate from the reference range on the pre-examination basis. 9.Subjects who are pregnant, breast-feeding, or willing to become pregnant during the study period 10.Patients with a current or past history of psychiatric disorders (depression, etc.) 11.Employees working during night shifts, etc. 12.Alcoholism, drug dependence, and drug abusers who are or have a history of treatment 13.Subjects who have participated in other human clinical studies within the past 3 months or are expected to participate in other human clinical studies during the study period. 14.Other than the above, the principal investigator judged the subject to be inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum uric acid levels | — |
Secondary
| Measure | Time frame |
|---|---|
| Urate clearance,Urinary uric acid excretion | — |
Countries
Japan
Contacts
Public ContactOchitani Daisuke
HUMA R&D CORP Clinical Development Division
Outcome results
None listed